Western blotting is a molecular biology technique used for detecting specific proteins in a given sample of tissue homogenate or extract. The technique uses gel electrophoresis to separate native or denatured proteins by the length of the polypeptide chain and antibodies labeled with enzymes to detect the presence of a specific protein. Western blotting provides advantages such as high sensitivity, specificity, and parallel analysis of multiple samples. The increasing prevalence of infectious diseases and chronic diseases has propelled research around disease diagnosis and treatment development. This has increased the demand for western blotting as it enables visualization of proteins associated with these diseases. The global Western Blotting Market is estimated to be valued at US$ 759.05 Mn in 2023 and is expected to exhibit a CAGR of 6.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends driving the growth of the western blotting market is the rising demand for biomarker research. Biomarker research aims to identify molecular signatures correlated with diseases or clinical conditions. Researchers are exploring protein biomarkers related to various cancer types, infectious diseases, autoimmune disorders, and neurological disorders to facilitate better disease diagnosis and targeted therapeutics. Western blotting is widely utilized in biomarker research as it allows researchers to detect specific proteins and measure their intensities in biological samples obtained from control and disease groups. This trend is expected to continue boosting the demand for western blotting kits, reagents, and consumables over the forecast period.
Segment Analysis
The global western blotting market is primarily segmented into product, end users and application. Based on product, instruments dominated the western blotting market in 2020 due to their wide usage in biotechnological and pharmaceutical companies. The instruments segment is further divided into gel electrophoresis instrument, blotting systems, imaging systems and ancillary equipment. Imaging systems sub segment dominated the instruments market owing to their ability to visualize and automatically analyze the western blot results accurately.
Key Takeaways
The global western blotting market is expected to witness high growth.
Regional analysis: North American region currently holds the largest share of the western blotting market and is expected to maintain its dominance over the forecast period. The high growth in the region is attributed to the early availability of advanced technologies, increasing funding for R&D from both private and public bodies and growing proteomics research.
Key players related content comprises Key players operating in the western blotting market are Thermo Fisher Scientific, Inc., GE HealthCare, F. Hoffmann-La Roche Ltd, Lumigen, Inc., Merck KGaA, Bio-Rad Laboratories, Inc., LI-COR, Inc., Bio-Techne, SBH Sciences, Advansta Inc., Azure Biosystems Inc., HiMedia Laboratories., Elabscience Biotechnology Inc., GenScript, Cell Signaling Technology, Inc., ICL, Inc., Takara Bio Inc., Leinco Technologies.
No comments:
Post a Comment